PERSPECTA

News from every angle

← Back to headlines

Argenx Leads European Biotech Surge with Trial Success

European biotech firm Argenx has seen its stock soar following successful trial results, contributing to a strong week for biotech stocks across the Atlantic.

21 Aug, 06:27 — 21 Aug, 06:27
PostShare

Sources

Showing 1 of 1 sources
bloombergHigh3d ago

Europe Has Its Own Biotech Star as Argenx Soars on Trial Success

It’s been a big week for biotech stocks on both sides of the Atlantic.

By Lisa Pham

Read full article →

Related Stories

Oil Prices Steady as Investors Weigh Expanded US Sanctions Against Iran

15m ago

Hanwha Aerospace to Establish US Entity for LNG Business

19m ago

Saudi Arabia and France Deepen Economic and Cultural Ties During MBS Visit

29m ago

Dollar Struggles Amid Iran Sanctions and Treasury Buybacks

32m ago